Annual Revenue
$146.03 M
-$11.04 M-7.03%
December 31, 2023
Summary
- As of February 20, 2025, KPTI annual revenue is $146.03 million, with the most recent change of -$11.04 million (-7.03%) on December 31, 2023.
- During the last 3 years, KPTI annual revenue has risen by +$37.95 million (+35.11%).
- KPTI annual revenue is now -30.40% below its all-time high of $209.82 million, reached on December 31, 2021.
Performance
KPTI Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$38.78 M
-$4.00 M-9.36%
September 30, 2024
Summary
- As of February 20, 2025, KPTI quarterly revenue is $38.78 million, with the most recent change of -$4.00 million (-9.36%) on September 30, 2024.
- Over the past year, KPTI quarterly revenue has stayed the same.
- KPTI quarterly revenue is now -69.29% below its all-time high of $126.27 million, reached on December 31, 2021.
Performance
KPTI Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$148.44 M
+$2.77 M+1.90%
September 30, 2024
Summary
- As of February 20, 2025, KPTI TTM revenue is $148.44 million, with the most recent change of +$2.77 million (+1.90%) on September 30, 2024.
- Over the past year, KPTI TTM revenue has stayed the same.
- KPTI TTM revenue is now -40.93% below its all-time high of $251.31 million, reached on June 30, 2022.
Performance
KPTI TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
KPTI Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.0% | 0.0% | 0.0% |
| 3 y3 years | +35.1% | +2.9% | +25.1% |
| 5 y5 years | +381.4% | +194.9% | +263.0% |
KPTI Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -30.4% | at low | -69.3% | +17.1% | -40.9% | +5.7% |
| 5 y | 5-year | -30.4% | +257.1% | -69.3% | +114.3% | -40.9% | +263.0% |
| alltime | all time | -30.4% | >+9999.0% | -69.3% | >+9999.0% | -40.9% | >+9999.0% |
Karyopharm Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $38.78 M(-9.4%) | $148.44 M(+1.9%) |
| Jun 2024 | - | $42.79 M(+29.2%) | $145.67 M(+3.7%) |
| Mar 2024 | - | $33.13 M(-1.8%) | $140.46 M(-3.8%) |
| Dec 2023 | $146.03 M(-7.0%) | $33.75 M(-6.3%) | $146.03 M(+0.1%) |
| Sep 2023 | - | $36.01 M(-4.2%) | $145.87 M(-0.1%) |
| Jun 2023 | - | $37.58 M(-2.9%) | $146.00 M(-1.4%) |
| Mar 2023 | - | $38.70 M(+15.2%) | $148.10 M(-5.7%) |
| Dec 2022 | $157.07 M(-25.1%) | $33.58 M(-7.1%) | $157.07 M(-37.1%) |
| Sep 2022 | - | $36.15 M(-8.9%) | $249.76 M(-0.6%) |
| Jun 2022 | - | $39.68 M(-16.8%) | $251.31 M(+7.3%) |
| Mar 2022 | - | $47.67 M(-62.2%) | $234.23 M(+11.6%) |
| Dec 2021 | $209.82 M(+94.1%) | $126.27 M(+235.0%) | $209.82 M(+76.8%) |
| Sep 2021 | - | $37.69 M(+66.8%) | $118.65 M(+16.0%) |
| Jun 2021 | - | $22.60 M(-2.8%) | $102.29 M(-9.6%) |
| Mar 2021 | - | $23.26 M(-33.7%) | $113.21 M(+4.7%) |
| Dec 2020 | $108.08 M(+164.3%) | $35.10 M(+64.5%) | $108.08 M(+18.7%) |
| Sep 2020 | - | $21.33 M(-36.3%) | $91.08 M(+9.9%) |
| Jun 2020 | - | $33.51 M(+84.8%) | $82.90 M(+40.8%) |
| Mar 2020 | - | $18.14 M(+0.2%) | $58.88 M(+44.0%) |
| Dec 2019 | $40.89 M(+34.8%) | $18.10 M(+37.6%) | $40.89 M(+77.8%) |
| Sep 2019 | - | $13.15 M(+38.5%) | $23.00 M(+127.9%) |
| Jun 2019 | - | $9.49 M(+6024.5%) | $10.09 M(-50.7%) |
| Mar 2019 | - | $155.00 K(-24.8%) | $20.49 M(-32.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $30.34 M(+1790.1%) | $206.00 K(-13.8%) | $30.34 M(-4.2%) |
| Sep 2018 | - | $239.00 K(-98.8%) | $31.66 M(+0.8%) |
| Jun 2018 | - | $19.89 M(+98.9%) | $31.43 M(+172.4%) |
| Mar 2018 | - | $10.00 M(+551.9%) | $11.54 M(+618.8%) |
| Dec 2017 | $1.60 M(+942.2%) | $1.53 M(>+9900.0%) | $1.60 M(+866.9%) |
| Jun 2017 | - | $3000.00(-95.6%) | $166.00 K(-25.2%) |
| Mar 2017 | - | $68.00 K(+44.7%) | $222.00 K(+44.2%) |
| Dec 2016 | $154.00 K(-38.4%) | $47.00 K(-2.1%) | $154.00 K(+16.7%) |
| Sep 2016 | - | $48.00 K(-18.6%) | $132.00 K(-17.0%) |
| Jun 2016 | - | $59.00 K(+136.0%) | $159.00 K(-36.4%) |
| Dec 2015 | $250.00 K(+9.2%) | $25.00 K(-66.7%) | $250.00 K(+4.2%) |
| Sep 2015 | - | $75.00 K(-50.0%) | $240.00 K(+29.0%) |
| Jun 2015 | - | $150.00 K(+900.0%) | $186.00 K(-18.4%) |
| Dec 2014 | $229.00 K(-40.8%) | $15.00 K(-28.6%) | $228.00 K(-2.6%) |
| Sep 2014 | - | $21.00 K(0.0%) | $234.00 K(+9.9%) |
| Jun 2014 | - | $21.00 K(-87.7%) | $213.00 K(-34.5%) |
| Mar 2014 | - | $171.00 K(+714.3%) | $325.00 K(-16.0%) |
| Dec 2013 | $387.00 K(-39.0%) | $21.00 K(-84.2%) | $387.00 K(-10.6%) |
| Jun 2013 | - | $133.00 K(-42.9%) | $433.00 K(+44.3%) |
| Mar 2013 | - | $233.00 K(+606.1%) | $300.00 K(+347.8%) |
| Dec 2012 | $634.00 K(+317.1%) | $33.00 K(-2.9%) | $67.00 K(+97.1%) |
| Sep 2012 | - | $34.00 K | $34.00 K |
| Dec 2011 | $152.00 K | - | - |
FAQ
- What is Karyopharm Therapeutics annual revenue?
- What is the all time high annual revenue for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual revenue year-on-year change?
- What is Karyopharm Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly revenue year-on-year change?
- What is Karyopharm Therapeutics TTM revenue?
- What is the all time high TTM revenue for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics TTM revenue year-on-year change?
What is Karyopharm Therapeutics annual revenue?
The current annual revenue of KPTI is $146.03 M
What is the all time high annual revenue for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual revenue is $209.82 M
What is Karyopharm Therapeutics annual revenue year-on-year change?
Over the past year, KPTI annual revenue has changed by -$11.04 M (-7.03%)
What is Karyopharm Therapeutics quarterly revenue?
The current quarterly revenue of KPTI is $38.78 M
What is the all time high quarterly revenue for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly revenue is $126.27 M
What is Karyopharm Therapeutics quarterly revenue year-on-year change?
Over the past year, KPTI quarterly revenue has changed by $0.00 (0.00%)
What is Karyopharm Therapeutics TTM revenue?
The current TTM revenue of KPTI is $148.44 M
What is the all time high TTM revenue for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high TTM revenue is $251.31 M
What is Karyopharm Therapeutics TTM revenue year-on-year change?
Over the past year, KPTI TTM revenue has changed by $0.00 (0.00%)